https://idwiki.org/index.php?action=history&feed=atom&title=Carbapenem-resistant_Enterobacterales 2026-04-25T23:13:54Z Revision history for this page on the wiki MediaWiki 1.43.8 https://idwiki.org/index.php?title=Carbapenem-resistant_Enterobacterales&diff=11383&oldid=prev 2025-11-22T17:01:16Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:01, 22 November 2025</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Management ==</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Management ==</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> <tr> <td colspan="2" class="diff-empty diff-side-deleted"></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* See also [[Carbapenem-resistant organisms]]</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]] or [[aztreonam]] 2 g IV q8h plus [[ceftazidime-avibactam]] 2.5 g IV q8h (both run concurrently over 3 hours)</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]] or [[aztreonam]] 2 g IV q8h plus [[ceftazidime-avibactam]] 2.5 g IV q8h (both run concurrently over 3 hours)</div></td> </tr> <!-- diff cache key site7_mediawiki:diff:1.41:old-11381:rev-11383:wikidiff2=table:1.13.0:bc2a06be --> </table>

Aidan https://idwiki.org/index.php?title=Carbapenem-resistant_Enterobacterales&diff=11381&oldid=prev 2025-11-22T17:00:10Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:00, 22 November 2025</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 2:</td> <td colspan="2" class="diff-lineno">Line 2:</td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> </tr> <tr> <td class="diff-marker" data-marker="−"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]] or [[aztreonam]] plus [[ceftazidime-avibactam]]</div></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]] or [[aztreonam]]<ins style="font-weight: bold; text-decoration: none;"> 2 g IV q8h</ins> plus [[ceftazidime-avibactam]]<ins style="font-weight: bold; text-decoration: none;"> 2.5 g IV q8h (both run concurrently over 3 hours)</ins></div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For non-severe infections, consider [[aminoglycosides]], including [[plazomicin]]; [[tigecycline]] would be second-line, though it can be considered in pneumonia</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For non-severe infections, consider [[aminoglycosides]], including [[plazomicin]]; [[tigecycline]] would be second-line, though it can be considered in pneumonia</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> </table>

Aidan https://idwiki.org/index.php?title=Carbapenem-resistant_Enterobacterales&diff=10952&oldid=prev 2024-11-14T02:27:24Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 02:27, 14 November 2024</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 2:</td> <td colspan="2" class="diff-lineno">Line 2:</td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]</div></td> </tr> <tr> <td class="diff-marker" data-marker="−"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]]</div></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol<ins style="font-weight: bold; text-decoration: none;">]] or [[aztreonam]] plus [[ceftazidime-avibactam</ins>]]</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For non-severe infections, consider [[aminoglycosides]], including [[plazomicin]]; [[tigecycline]] would be second-line, though it can be considered in pneumonia</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* For non-severe infections, consider [[aminoglycosides]], including [[plazomicin]]; [[tigecycline]] would be second-line, though it can be considered in pneumonia</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> </table>

Aidan https://idwiki.org/index.php?title=Carbapenem-resistant_Enterobacterales&diff=10951&oldid=prev 2024-11-14T02:26:12Z

<p>Created page with &quot;== Management == * First-line includes <a href="/Meropenem-vaborbactam" title="Meropenem-vaborbactam">meropenem-vaborbactam</a> or <a href="/Ceftazidime-avibactam" title="Ceftazidime-avibactam">ceftazidime-avibactam</a>, directed by susceptibility results<a href="/index.php?title=CiteRef:paul2022eu&amp;action=edit&amp;redlink=1" class="new" title="CiteRef:paul2022eu (page does not exist)">CiteRef:paul2022eu</a> * For metallo-β-lactamases or extensively resistant bacteria, consider <a href="/Cefiderocol" title="Cefiderocol">cefiderocol</a> * For non-severe infections, consider <a href="/Aminoglycosides" title="Aminoglycosides">aminoglycosides</a>, including <a href="/Plazomicin" title="Plazomicin">plazomicin</a>; <a href="/Tigecycline" title="Tigecycline">tigecycline</a> would be second-line, though it can be considered in pneumonia <a href="/index.php?title=Category:Antimicrobial_resistance&amp;action=edit&amp;redlink=1" class="new" title="Category:Antimicrobial resistance (page does not exist)">Category:Antimicrobial resistance</a>&quot;</p> <p><b>New page</b></p><div>== Management ==<br /> <br /> * First-line includes [[meropenem-vaborbactam]] or [[ceftazidime-avibactam]], directed by susceptibility results[[CiteRef:paul2022eu]]<br /> * For metallo-β-lactamases or extensively resistant bacteria, consider [[cefiderocol]]<br /> * For non-severe infections, consider [[aminoglycosides]], including [[plazomicin]]; [[tigecycline]] would be second-line, though it can be considered in pneumonia<br /> <br /> [[Category:Antimicrobial resistance]]</div>

Aidan